Kendra DeBusk

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Eric L. Simpson, Carsten Flohr, Lawrence F. Eichenfield et al. · Journal of the American Academy of Dermatology · 2018 · 325 citations · Full text

Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia

Sarah Acaster, Rene Dickerhoof, Kendra DeBusk et al. · Health and Quality of Life Outcomes · 2015 · 88 citations · Full text

Assessing the quality of life of health-referred children and adolescents with short stature: development and psychometric testing of the QoLISSY instrument

Monika Bullinger, Julia Quitmann, Mick Power et al. · Health and Quality of Life Outcomes · 2013 · 80 citations · Full text

Development and validation of the Crohn’s disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary

Peter Higgins, Gale Harding, Nancy Kline Leidy et al. · Journal of Patient-Reported Outcomes · 2018 · 47 citations · Full text

Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diary

Peter Higgins, Gale Harding, Dennis A. Revicki et al. · Journal of Patient-Reported Outcomes · 2018 · 46 citations · Full text